Loading...
Loading...
India's calcium imports from UNITED STATES total $1.7M across 283 shipments from 15 foreign suppliers. M/S. ENDO USA, INC leads with $888.0K in import value; the top 5 suppliers together control 81.0% of this origin. Leading Indian buyers include PAR FORMULATIONS PRIVATE LIMITED. This corridor reflects India's pharmaceutical import demand for calcium — a diversified sourcing base with multiple active suppliers from UNITED STATES.

M/S. ENDO USA, INC is the leading Calcium supplier from UNITED STATES to India, with import value of $888.0K across 6 shipments. The top 5 suppliers — M/S. ENDO USA, INC, PCI PHARMA SERVICES, K.PATEL PHYTO EXTRACTIONS PVT.LTD., NEWLIFE MEDICALS (USA).INC., ENDO PHARMACEUTICALS SOLUTIONS INC. — collectively account for 81.0% of total import value from this origin.
Ranked by import value (USD) · Indian Customs (DGFT) data
| # | Supplier | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | M/S. ENDO USA, INC | $888.0K | 6 | 51.9% |
| 2 | PCI PHARMA SERVICES | $211.1K | 3 | 12.3% |
| 3 | K.PATEL PHYTO EXTRACTIONS PVT.LTD. | $160.2K | 1 | 9.4% |
| 4 | NEWLIFE MEDICALS (USA).INC. | $66.5K | 1 | 3.9% |
| 5 | ENDO PHARMACEUTICALS SOLUTIONS INC. | $59.9K | 18 | 3.5% |
| 6 | AMSTERDAM PHARMA(APTEKA RX INC.) | $31.5K | 23 | 1.8% |
| 7 | ESPEE BIOPHARMA & FINECHEM LLC | $25.7K | 5 | 1.5% |
| 8 | AGRACE PHARMA | $24.2K | 14 | 1.4% |
| 9 | Pharmaceutical Buyers, Inc | $23.5K | 15 | 1.4% |
| 10 | AMSTERDAM PHARMA APTEKA RX INC | $17.2K | 13 | 1.0% |
| 11 | AMSTERDAM PHARMA (APTEKA RX INC) | $14.4K | 10 | 0.8% |
| 12 | M/S RAFF & HALL PHARMACY | $13.7K | 4 | 0.8% |
| 13 | HEALTH CARE II DRUGS,INC | $12.8K | 1 | 0.7% |
| 14 | SPRING BIO SOLUTION. | $11.4K | 5 | 0.7% |
| 15 | ENDO PHARMACEUTICALS SOLUTIONS INC | $10.5K | 1 | 0.6% |
Ranked by import value (USD)
| # | Buyer | Value (USD) | Shipments | Share |
|---|---|---|---|---|
| 1 | PAR FORMULATIONS PRIVATE LIMITED | $966.3K | 27 | 56.5% |
| 2 | JSS MEDICAL RESEARCH INDIA PRIVATE LIMITED | $193.6K | 2 | 11.3% |
| 3 | K PATEL PHYTO EXTRACTIONS PRIVATE LIMITED | $160.2K | 1 | 9.4% |
| 4 | UMEDICA LABORATORIES PRIVATE LIMITED | $66.5K | 1 | 3.9% |
| 5 | MYLAN LABORATORIES LIMITED | $25.3K | 15 | 1.5% |
| 6 | INTAS PHARMACEUTICALS LIMITED | $18.3K | 7 | 1.1% |
| 7 | DR.REDDY'S LABORATORIES LTD | $17.7K | 18 | 1.0% |
| 8 | JSS MEDICAL RESEARCH ASIA PACIFIC PRIVATE LIMITED | $17.5K | 1 | 1.0% |
| 9 | EXTROVIS PRIVATE LIMITED | $16.8K | 13 | 1.0% |
| 10 | AMNEAL PHARMACEUTICALS PRIVATE LIMITED | $16.5K | 5 | 1.0% |
| 11 | GRAVITI PHARMACEUTICALS PRIVATE LIMITED | $16.5K | 8 | 1.0% |
| 12 | CIPLA LIMITED | $15.8K | 7 | 0.9% |
| 13 | DR.REDDY'S LABORATORIES LIMITED | $13.8K | 5 | 0.8% |
| 14 | ALEMBIC PHARMACEUTICALS LIMITED | $12.8K | 5 | 0.7% |
| 15 | DR REDDYS LABORATORIES LIMITED | $11.6K | 10 | 0.7% |
Answers based on Indian Customs (DGFT) import records compiled by TransData Nexus
The top Calcium suppliers from UNITED STATES to India include M/S. ENDO USA, INC, PCI PHARMA SERVICES, K.PATEL PHYTO EXTRACTIONS PVT.LTD.. The leading supplier is M/S. ENDO USA, INC with import value of $888.0K USD across 6 shipments. India imported Calcium worth $1.7M USD from UNITED STATES in total across 283 shipments.
India imported Calcium worth $1.7M USD from UNITED STATES across 283 shipments. Data is from Indian Customs (DGFT) records. Values are in USD.
The main Indian buyers of Calcium sourced from UNITED STATES include PAR FORMULATIONS PRIVATE LIMITED, JSS MEDICAL RESEARCH INDIA PRIVATE LIMITED, K PATEL PHYTO EXTRACTIONS PRIVATE LIMITED. The largest buyer is PAR FORMULATIONS PRIVATE LIMITED with $966.3K in imports across 27 shipments.
The total value of Calcium imports from UNITED STATES to India is $1.7M USD, across 283 shipments and 15 foreign suppliers. Data source: Indian Customs (DGFT).
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Pharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormareAll trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
283 Verified Shipments
15 suppliers, 15 buyers tracked
Expert-Reviewed
By pharmaceutical trade specialists